Danaher Corporation (DHR)Executive Vice President sold ~$1.59M

~$1.59M

Approx. value · 8,004 sh @ $198.05

15K

Holds after · shares reported

Traded

Apr 30, 2025

Filed

May 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
2. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
3. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
4. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
5. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
6. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
7. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
8. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
9. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
10. Apr 30, 2025 · this disclosureInsiderOfficer sold ~$1.59M of DHR shares in the open market

What came next

1. Apr 30, 2025InsiderOfficer sold ~$1.54M of DHR shares in the open market
2. May 12, 2025Insider · 1 personInsiders: 8 sales (~$245.9M)
3. May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
4. May 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
5. Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
6. Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
7. Jun 25, 2025FDARecall: DxI 800 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71457
8. Jun 25, 2025FDARecall: DxI 600 Access Immunoassay Analyzer W/Spot B, Part Number A71460
9. Jun 26, 2025FDARecall: UIBC (Unsaturated Iron Binding Capacity), REF: OSR61205,
10. Jul 10, 2025FDARecall: Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860
11. Jul 18, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)
12. Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
13. Jul 24, 2025FDARecall: MicroScan Neg MIC 56 REF C42464 UDI-DI code: 15099590731212 MicroScan panels are designed for use in determining antimicrobial agent susceptibility and/or iden…
14. Aug 1, 2025FDAFDA device clearance: Access hsTnI
15. Aug 4, 2025FDARecall: DxC 500 AU Module w/ISE, DxC 500i, With ISE, REF: C63522 and DxC 500 AU Module, DxC 500i, Without ISE, REF: C6352; part of the DxC 500i Clinical Analyzer
16. Aug 6, 2025FDARecall: Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of reagents and other as…
17. Aug 13, 2025FDARecall: UniCel DxH 800 COULTER Cellular Analysis System, configured with the Led HGB Photometer REFs:B24802, 629029, B63322
18. Aug 13, 2025FDARecall: UniCel DxH 900 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C11478
19. Aug 13, 2025FDARecall: UniCel DxH 690T COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C34520
20. Aug 13, 2025FDARecall: UniCel DxH 600 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF:B23858

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Christopher Paul Riley, Executive Vice President

• SEC Form 4 at Danaher Corporation (DHR)May 1, 2025

The full history of Christopher Paul Riley, Executive Vice President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Danaher Corporation

• House Clerk periodic transaction reportSep 25, 2026
• House Clerk periodic transaction reportSep 25, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 13F-HRAug 18, 2026

Everything OQRO holds on this company is on its DHR page.